October 16, 2020
Friday, April 12, 2013
ALACHUA – Today, Governor Rick Scott announced that Nanotherapeutics, Inc., a privately held biopharmaceutical company based in the City of Alachua, will create 150 jobs at a manufacturing facility to be built as a result of a biodefense contract awarded last month by the Department of Defense. The company also will retain 45 positions, offer an average annual wage of $90,000 for these positions, and make a capital investment of $127 million.
Governor Scott said, “Thanks in part to the great STEM and business-support resources that UF provides to the region, Nanotherapeutics is going to create 150 jobs for families in Alachua. We’ve worked to cut taxes and pay down debt, and this year my Florida Families First Budget provides an additional $15 million to UF to achieve top 10 national status, which will foster more job growth for families throughout Florida. Through these strategies, we’ve created nearly 300,000 private sector jobs for families across the Sunshine State. We’ll continue working to provide families with more jobs and opportunities, so every Florida family can pursue the American Dream.”
Florida was able to provide Nanotherapeutics with resources to ensure its continuing growth in our state. This is a victory for the families and communities that will be served by this company’s investment and the new jobs that are coming with its expansion.”
The overall contract was awarded for $135 million, with additional options included that could bring the total award to $358 million. The funding is to be used to establish a Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) capability for the Department of Defense (DOD). This will enable faster and more effective development of medical countermeasures to protect and treat military populations against chemical, biological, radiological and nuclear attacks and outbreaks of naturally occurring emerging and genetically engineering infectious diseases.
“The Innovation Gainesville (iG) economic development plan clearly identifies the life sciences as a top opportunity for job growth,” said John Carlson, chairman of the Council for Economic Outreach. “Nanotherapeutics’ brings that opportunity to reality and demonstrates that we are committed to growing jobs, growing companies and growing opportunities right here in Alachua County.”
“The City of Alachua is always ready to respond to the needs of businesses,” said Mayor Gib Coerper. “We are so proud that our local start-up Nanotherapeutics will expand their company in Alachua and will be serving our country in a special way, providing this type of product to our military and others. We thank the leadership of the company for making an investment in our community.”
“It is so exciting to see the success and expansion of a local company,” said Lee Pinkoson, Vice-Chair of the Alachua Board of County Commissioners. “Alachua County is pleased to be a government partner and we look forward to the new jobs and manufacturing opportunity that this project creates.”
“Nanotherapeutics’ decision to move forward in Alachua demonstrates that Florida’s wide diversity of communities is a competitive strength regardless of their size and population. We provide a business climate that encourages companies to expand and create jobs here, said Florida Secretary of Commerce Gray Swoope, who serves as president & CEO of Enterprise Florida Inc., the state’s lead economic development organization.”
The contract was granted to Nanotherapeutics, as the prime contractor, and its industry partners after a highly competitive bid process. The ultimate goal for the award is to reduce the overall time and cost associated with the development and manufacturing of Food and Drug Administration approved Medical Counter Measures.
Headquartered in Alachua and currently operating in Progress Corporate Park, Nanotherapeutics began as a start-up in the Sid Martin Biotechnology Incubator. Nanotherapeutics will integrate into a new state-of-the-art facility flexible, single use, disposable equipment that can provide our military’s national security requirements for Medical Counter Measures now and in the foreseeable future.
Nanotherapeutics has assembled a world class team of partners from throughout the United States to apply new biomanufacturing technologies with existing manufacturing capabilities for small molecule and biologic products that will provide the DOD with the ability to rapidly respond to chemical, biological, radiological, and nuclear attacks and outbreaks of naturally occurring emerging and genetically engineered infectious diseases.